Colgate-Palmolive (NYSE:CL) Shares Sold by Schnieders Capital Management LLC

Schnieders Capital Management LLC lowered its position in Colgate-Palmolive (NYSE:CL) by 30.4% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 14,849 shares of the company’s stock after selling 6,495 shares during the period. Schnieders Capital Management LLC’s holdings in Colgate-Palmolive were worth $1,184,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. Morgan Stanley lifted its position in Colgate-Palmolive by 3.2% during the third quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock valued at $1,195,785,000 after purchasing an additional 514,559 shares during the period. Northern Trust Corp raised its position in Colgate-Palmolive by 3.3% during the third quarter. Northern Trust Corp now owns 9,452,931 shares of the company’s stock valued at $672,198,000 after acquiring an additional 305,862 shares in the last quarter. American Century Companies Inc. raised its position in Colgate-Palmolive by 2.0% during the third quarter. American Century Companies Inc. now owns 6,590,405 shares of the company’s stock valued at $468,644,000 after acquiring an additional 127,805 shares in the last quarter. FMR LLC lifted its holdings in Colgate-Palmolive by 27.3% in the third quarter. FMR LLC now owns 5,597,742 shares of the company’s stock valued at $398,055,000 after acquiring an additional 1,199,660 shares during the period. Finally, Nordea Investment Management AB boosted its position in Colgate-Palmolive by 10.1% in the 3rd quarter. Nordea Investment Management AB now owns 5,455,384 shares of the company’s stock worth $390,005,000 after purchasing an additional 500,916 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently issued reports on CL. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research note on Thursday, January 18th. Stifel Nicolaus increased their target price on shares of Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a research note on Wednesday, April 10th. Evercore ISI lifted their price target on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research note on Monday, April 8th. Barclays increased their price target on Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, April 12th. Finally, Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective for the company in a research report on Monday, January 29th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus target price of $89.50.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Jennifer Daniels sold 61,633 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $83.93, for a total value of $5,172,857.69. Following the completion of the sale, the insider now directly owns 57,948 shares of the company’s stock, valued at approximately $4,863,575.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, insider Jennifer Daniels sold 61,633 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $83.93, for a total value of $5,172,857.69. Following the transaction, the insider now directly owns 57,948 shares in the company, valued at $4,863,575.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Gregory Malcolm sold 8,930 shares of the stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $85.35, for a total value of $762,175.50. Following the completion of the transaction, the executive vice president now owns 8,043 shares of the company’s stock, valued at $686,470.05. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 232,371 shares of company stock valued at $19,505,099. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE CL traded up $0.25 during mid-day trading on Tuesday, reaching $88.58. The company’s stock had a trading volume of 4,014,765 shares, compared to its average volume of 4,556,424. The stock has a 50-day moving average of $87.29 and a two-hundred day moving average of $81.20. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. The stock has a market capitalization of $72.81 billion, a P/E ratio of 31.86, a P/E/G ratio of 3.27 and a beta of 0.42. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $90.37.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. During the same quarter in the prior year, the firm earned $0.77 EPS. Colgate-Palmolive’s quarterly revenue was up 6.9% on a year-over-year basis. On average, equities research analysts anticipate that Colgate-Palmolive will post 3.5 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a dividend of $0.50 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a yield of 2.26%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 71.94%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.